GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: THLDD
Overweight

THRESHOLD PHARMACEUT (NASDAQ: THLD) upgraded to Overweight by Piper Jaffray

Wednesday,  Feb 20, 2013  8:25 AM ET by Betsy O'Brien Harrison

Piper Jaffray upgraded THRESHOLD PHARMACEUT (NASDAQ: THLD) to Overweight. Previously
Piper Jaffray upgraded to THRESHOLD PHARMACEUT (NASDAQ: THLD) to Neutral on 01/18/2013, when the stock price was $4.48.

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy